Double Seronegative Myasthenia Gravis with Anti-LRP4 Antibodies Presenting with Dropped Head and Acute Respiratory Insufficiency
Author:
Affiliation:
1. Department of Neurology, Osaka University Graduate School of Medicine, Japan
2. Department of Clinical Research, Nagasaki Kawatana Medical Center, Japan
3. Department of Neurology, Nagasaki Kawatana Medical Center, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/55/22/55_55.7030/_pdf
Reference19 articles.
1. 1. Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest 116: 2843-2854, 2006.
2. 2. Richman DP, Agius MA, Kirvan CA, et al. Antibody effector mechanisms in myasthenia gravis. The complement hypothesis. Ann NY Acad Sci 841: 450-465, 1998.
3. 3. Zhang B, Tzartos JS, Belimezi M, et al. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol 69: 445-451, 2012.
4. 4. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60: 1978-1980, 2003.
5. 5. Higuchi O, Hamuro J, Motomura M, Yamanashi Y. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69: 418-422, 2011.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unusual Presentation of Double-seronegative Myasthenia Gravis with Positive Anti-LRP4 Antibody: Diagnostic Utility of a Videofluoroscopic Swallowing Study;Internal Medicine;2024
2. Conventional and emerging treatments and controversies in myasthenia gravis;Expert Review of Neurotherapeutics;2023-05-03
3. Heterogeneity in myasthenia gravis: considerations for disease management;Expert Review of Clinical Immunology;2021-06-22
4. Clinical features of LRP4 /agrin‐antibody–positive myasthenia gravis: A multicenter study;Muscle & Nerve;2020-06-10
5. New Approaches to Targeting B Cells for Myasthenia Gravis Therapy;Frontiers in Immunology;2020-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3